Ernest S Han

6PUBLICATIONS
28CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Nov 27, 2025
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin.

Alison L Dumitriu, Wei Wen, Jin Yan

|Sep 05, 2025
From Fallopian Tube to Ovarian Cancer: Understanding the Evaluation and Management of Serous Tubal Intraepithelial Carcinoma Lesions.

Vinita Popat, Ernest Han

|Sep 07, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).

Janos L Tanyi, Leslie M Randall, Setsuko K Chambers

|Mar 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.

Thanh H Dellinger, Ernest S Han, Mustafa Raoof

|Aug 01, 2020
Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles.

Tom Haber, Yvonne R Cornejo, Soraya Aramburo

Pageof 1

Frequent Collaborators

3 joint publications

Thanh H Dellinger

2 joint publications

Mark T Wakabayashi

2 joint publications

Hyejin Cho

2 joint publications

Daniel Schmolze